Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street ...

Thakral succeeds Interim CEO, Peter M. Neupert, who will remain chairman of the board DURHAM, N.C., June 11, 2025 (GLOBE ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & ...

Called Evinova, the new unit has emerged with alliances already in place with contract research organisations Parexel and Fortrea ... and planning of new clinical trials, drawing on artificial ...

Fortrea (Nasdaq: FTRE) (the "Company"), a leading global contract research organization (CRO), today announced that Fortrea's Board of Directors (the ...

commercial insights and relentless focus on customer engagement make him ideally suited to lead Fortrea. Further, he also shares the Company’s commitment to modernizing the clinical trials ...

Gainey McKenna & Egleston has filed a class action lawsuit against Fortrea over claims that it misled investors about revenue and cost savings following its spin-off.

Prosper Stars & Stripes, a long/short equity fund, recently released its first quarter 2025 investor letter. A copy of the ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...